Display options
Cite
Jaeschke H, Xie Y, McGill MR. Acetaminophen-induced Liver Injury: from Animal Models to Humans. J Clin Transl Hepatol. 2014;2(3):153-61doi: 10.14218/JCTH.2014.00014.
Jaeschke, H., Xie, Y., & McGill, M. R. (2014). Acetaminophen-induced Liver Injury: from Animal Models to Humans. Journal of clinical and translational hepatology, 2(3), 153-61. https://doi.org/10.14218/JCTH.2014.00014
Jaeschke, Hartmut, et al. "Acetaminophen-induced Liver Injury: from Animal Models to Humans." Journal of clinical and translational hepatology vol. 2,3 (2014): 153-61. doi: https://doi.org/10.14218/JCTH.2014.00014
Jaeschke H, Xie Y, McGill MR. Acetaminophen-induced Liver Injury: from Animal Models to Humans. J Clin Transl Hepatol. 2014 Sep;2(3):153-61. doi: 10.14218/JCTH.2014.00014. Epub 2014 Sep 15. PMID: 26355817; PMCID: PMC4521247.
Copy Download .nbib Format: NLM
Share it on

J Clin Transl Hepatol. 2014 Sep;2(3):153-61. doi: 10.14218/JCTH.2014.00014. Epub 2014 Sep 15.

Acetaminophen-induced Liver Injury: from Animal Models to Humans.

Journal of clinical and translational hepatology

Hartmut Jaeschke, Yuchao Xie, Mitchell R McGill

Affiliations

  1. Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.

PMID: 26355817 PMCID: PMC4521247 DOI: 10.14218/JCTH.2014.00014

Abstract

Drug-induced liver injury is an important clinical problem and a challenge for drug development. Whereas progress in understanding rare and unpredictable (idiosyncratic) drug hepatotoxicity is severely hampered by the lack of relevant animal models, enormous insight has been gained in the area of predictable hepatotoxins, in particular acetaminophen-induced liver injury, from a broad range of experimental models. Importantly, mechanisms of toxicity obtained with certain experimental systems, such as in vivo mouse models, primary mouse hepatocytes, and metabolically competent cell lines, are being confirmed in translational studies in patients and in primary human hepatocytes. Despite this progress, suboptimal models are still being used and experimental data can be confusing, leading to controversial conclusions. Therefore, this review attempts to discuss mechanisms of drug hepatotoxicity using the most studied drug acetaminophen as an example. We compare the various experimental models that are used to investigate mechanisms of acetaminophen hepatotoxicity, discuss controversial topics in the mechanisms, and assess how these experimental findings can be translated to the clinic. The success with acetaminophen in demonstrating the clinical relevance of experimental findings could serve as an example for the study of other drug toxicities.

Keywords: Drug hepatotoxicity; Necrosis; Sterile inflammation; Translational studies

References

  1. Gastroenterology. 2003 Oct;125(4):1246-57 - PubMed
  2. Toxicol Appl Pharmacol. 1992 Jan;112(1):32-40 - PubMed
  3. Hepatology. 2010 Jan;51(1):246-54 - PubMed
  4. Hepatology. 2007 May;45(5):1298-305 - PubMed
  5. Handb Exp Pharmacol. 2010;(196 ):165-94 - PubMed
  6. Liver Int. 2013 Apr;33(4):544-51 - PubMed
  7. J Pharmacol Exp Ther. 1995 Jun;273(3):1497-505 - PubMed
  8. J Clin Pharmacol. 2005 Oct;45(10):1165-71 - PubMed
  9. Toxicol Appl Pharmacol. 2014 Sep 15;279(3):266-74 - PubMed
  10. Gastroenterology. 2008 Oct;135(4):1311-21 - PubMed
  11. Biochem Biophys Res Commun. 2003 Apr 25;304(1):207-12 - PubMed
  12. Toxicol Appl Pharmacol. 2010 Jul;246(1-2):8-17 - PubMed
  13. Liver Int. 2010 Oct;30(9):1280-92 - PubMed
  14. Biochem Biophys Res Commun. 2003 Oct 3;309(4):857-63 - PubMed
  15. Lancet. 1977 Aug 27;2(8035):432-4 - PubMed
  16. Pharmacogenet Genomics. 2012 Nov;22(11):784-95 - PubMed
  17. Toxicol Sci. 2011 Aug;122(2):598-605 - PubMed
  18. Toxicol Appl Pharmacol. 2011 Mar 15;251(3):226-33 - PubMed
  19. J Leukoc Biol. 2008 Dec;84(6):1410-21 - PubMed
  20. Hepatology. 2004 Nov;40(5):1170-9 - PubMed
  21. J Biol Chem. 2010 Mar 12;285(11):8244-55 - PubMed
  22. Toxicol Appl Pharmacol. 1998 Sep;152(1):193-9 - PubMed
  23. Toxicol Appl Pharmacol. 2006 Oct 1;216(1):98-107 - PubMed
  24. Hepatology. 2013 Dec;58(6):2099-108 - PubMed
  25. Toxicol Pathol. 2012 Dec;40(8):1095-105 - PubMed
  26. Cancer Res. 2001 Feb 15;61(4):1659-65 - PubMed
  27. Clin Liver Dis. 2007 Aug;11(3):525-48, vi - PubMed
  28. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):122-33 - PubMed
  29. J Pharmacol Exp Ther. 2005 Nov;315 (2):879-87 - PubMed
  30. Redox Biol. 2013 Aug 26;1:427-32 - PubMed
  31. Toxicol Sci. 2006 Nov;94(1):217-25 - PubMed
  32. Hepatology. 2014 Apr;59(4):1543-54 - PubMed
  33. Am J Prev Med. 2011 Jun;40(6):585-92 - PubMed
  34. Gastroenterology. 2012 Nov;143(5):1158-72 - PubMed
  35. J Cell Physiol. 2007 Nov;213(2):286-300 - PubMed
  36. Toxicol Appl Pharmacol. 1990 Nov;106(2):346-51 - PubMed
  37. Toxicol Sci. 2001 Aug;62(2):212-20 - PubMed
  38. J Biol Chem. 2012 Dec 7;287(50):42379-88 - PubMed
  39. Toxicol Sci. 2004 Aug;80(2):343-9 - PubMed
  40. J Pharmacol Exp Ther. 1990 Dec;255 (3):935-41 - PubMed
  41. Hepatology. 2005 Jan;41(1):26-31 - PubMed
  42. Toxicol Appl Pharmacol. 1988 May;93(3):378-87 - PubMed
  43. J Biol Chem. 1989 Jun 15;264(17):9814-9 - PubMed
  44. Hepatology. 1990 Dec;12(6):1420-32 - PubMed
  45. Hepatology. 2010 Mar;51(3):1007-16 - PubMed
  46. Toxicol Lett. 2014 Mar 21;225(3):445-53 - PubMed
  47. Gastroenterology. 2014 Apr;146(4):914-28 - PubMed
  48. Hepatology. 2011 Mar;53(3):974-82 - PubMed
  49. Pharm Res. 2013 Sep;30(9):2174-87 - PubMed
  50. Mol Pharmacol. 2012 Nov;82(5):1001-7 - PubMed
  51. Arch Toxicol. 2013 Aug;87(8):1315-530 - PubMed
  52. J Pharmacol Exp Ther. 2003 Oct;307(1):67-73 - PubMed
  53. J Hepatol. 2005 Jan;42(1):110-6 - PubMed
  54. Toxicol Sci. 2009 Dec;112(2):521-31 - PubMed
  55. Toxicol Sci. 2000 Apr;54(2):509-16 - PubMed
  56. Toxicol Appl Pharmacol. 2013 Jun 15;269(3):240-9 - PubMed
  57. Hepatology. 2014 Oct;60(4):1336-45 - PubMed
  58. Hepatology. 2005 Jun;41(6):1252-61 - PubMed
  59. Clin Hemorheol Microcirc. 2006;34(1-2):5-10 - PubMed
  60. Hepatology. 2002 Feb;35(2):289-98 - PubMed
  61. Life Sci. 2006 Mar 6;78(15):1670-6 - PubMed
  62. J Pharmacol Exp Ther. 2008 Jan;324(1):8-14 - PubMed
  63. J Hepatol. 2012 May;56(5):1070-9 - PubMed
  64. Toxicol Pathol. 2009 Feb;37(2):193-200 - PubMed
  65. Hepatology. 1985 Mar-Apr;5(2):233-40 - PubMed
  66. Toxicol Sci. 2003 Oct;75(2):458-67 - PubMed
  67. Liver Int. 2012 Jan;32(1):8-20 - PubMed
  68. Toxicol Sci. 2011 Mar;120(1):109-22 - PubMed
  69. Toxicol Appl Pharmacol. 1997 Mar;143(1):1-12 - PubMed
  70. Toxicol Sci. 2002 Jun;67(2):322-8 - PubMed
  71. Toxicol Lett. 2010 Feb 15;192(3):387-94 - PubMed
  72. Free Radic Res. 2011 Feb;45(2):156-64 - PubMed
  73. Hepatology. 2014 Sep;60(3):977-89 - PubMed
  74. Biochem Pharmacol. 1997 May 9;53(9):1339-45 - PubMed
  75. Toxicol Sci. 2005 Mar;84(1):201-8 - PubMed
  76. Hepatology. 2012 Jan;55(1):222-32 - PubMed
  77. Cell Death Dis. 2013 May 09;4:e626 - PubMed
  78. Nat Rev Mol Cell Biol. 2004 Oct;5(10):836-47 - PubMed
  79. Microcirculation. 2003 Oct;10(5):391-400 - PubMed
  80. Drug Metab Rev. 2012 Feb;44(1):88-106 - PubMed
  81. Toxicol In Vitro. 2012 Dec;26(8):1278-85 - PubMed
  82. Liver Int. 2006 Oct;26(8):904-11 - PubMed
  83. J Pharmacol Exp Ther. 2010 Jul;334(1):33-43 - PubMed
  84. Pharmacol Rev. 2013 Mar 08;65(2):779-808 - PubMed
  85. Gastroenterology. 2006 Jul;131(1):165-78 - PubMed
  86. Hepatology. 2004 Jun;39(6):1477-87 - PubMed
  87. Toxicol Sci. 2003 Jun;73(2):386-402 - PubMed
  88. Arch Biochem Biophys. 1989 Jun;271(2):270-83 - PubMed
  89. Cell Biol Toxicol. 2012 Apr;28(2):69-87 - PubMed
  90. Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94 - PubMed
  91. Liver Transpl. 2006 Dec;12(12):1776-81 - PubMed
  92. Food Chem Toxicol. 2013 May;55:279-89 - PubMed
  93. J Clin Invest. 2012 Apr;122(4):1574-83 - PubMed
  94. J Biol Chem. 2008 May 16;283(20):13565-77 - PubMed
  95. Am J Pathol. 2009 Sep;175(3):1056-65 - PubMed
  96. Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G102-9 - PubMed
  97. J Biol Chem. 2011 Oct 7;286(40):35071-8 - PubMed
  98. Toxicol Sci. 2010 Sep;117(1):101-8 - PubMed
  99. FEBS Lett. 1999 Jan 8;442(1):117-21 - PubMed
  100. Toxicol Appl Pharmacol. 2003 Dec 1;193(2):218-27 - PubMed
  101. J Pharmacol Exp Ther. 1973 Oct;187(1):211-7 - PubMed
  102. Hepatology. 2012 Aug;56(2):735-46 - PubMed
  103. Basic Clin Pharmacol Toxicol. 2004 May;94(5):213-25 - PubMed
  104. Semin Respir Crit Care Med. 2012 Feb;33(1):36-45 - PubMed
  105. J Pharmacol Exp Ther. 2002 Nov;303(2):468-75 - PubMed
  106. Toxicol Sci. 2000 Nov;58(1):109-17 - PubMed
  107. J Biochem Mol Toxicol. 2000;14(4):177-88 - PubMed
  108. Nat Rev Drug Discov. 2005 Jun;4(6):489-99 - PubMed

Publication Types

Grant support